MX2007014447A - Variantes en cromosoma 8q24.21 que confieren riesgo de cancer. - Google Patents
Variantes en cromosoma 8q24.21 que confieren riesgo de cancer.Info
- Publication number
- MX2007014447A MX2007014447A MX2007014447A MX2007014447A MX2007014447A MX 2007014447 A MX2007014447 A MX 2007014447A MX 2007014447 A MX2007014447 A MX 2007014447A MX 2007014447 A MX2007014447 A MX 2007014447A MX 2007014447 A MX2007014447 A MX 2007014447A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- variants
- confer risk
- confer
- risk
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 3
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 102000054766 genetic haplotypes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68214705P | 2005-05-18 | 2005-05-18 | |
| US79576806P | 2006-04-28 | 2006-04-28 | |
| PCT/IS2006/000012 WO2006123369A1 (en) | 2005-05-18 | 2006-05-18 | Variants at chr8q24.21 confer risk of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007014447A true MX2007014447A (es) | 2008-04-16 |
Family
ID=36830953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007014447A MX2007014447A (es) | 2005-05-18 | 2006-05-18 | Variantes en cromosoma 8q24.21 que confieren riesgo de cancer. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090317799A1 (enExample) |
| EP (1) | EP1888772A1 (enExample) |
| JP (1) | JP5227167B2 (enExample) |
| AU (1) | AU2006248591B2 (enExample) |
| BR (1) | BRPI0610794A2 (enExample) |
| CA (1) | CA2608567A1 (enExample) |
| IL (1) | IL187449A (enExample) |
| MX (1) | MX2007014447A (enExample) |
| NZ (1) | NZ563913A (enExample) |
| WO (1) | WO2006123369A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2677994A1 (en) * | 2007-02-07 | 2008-08-14 | Decode Genetics Ehf. | Genetic variants contributing to risk of prostate cancer |
| EP2164984A2 (en) * | 2007-05-25 | 2010-03-24 | Decode Genetics EHF. | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
| US8697360B2 (en) * | 2007-11-30 | 2014-04-15 | Decode Genetics Ehf. | Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition |
| US20090226912A1 (en) * | 2007-12-21 | 2009-09-10 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US9732389B2 (en) | 2010-09-03 | 2017-08-15 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US9534256B2 (en) | 2011-01-06 | 2017-01-03 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer |
| WO2013065072A1 (en) * | 2011-10-30 | 2013-05-10 | Decode Genetics Ehf | Risk variants of prostate cancer |
| KR101944927B1 (ko) | 2016-03-24 | 2019-02-07 | 서울대학교산학협력단 | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| KR20250074712A (ko) | 2023-11-15 | 2025-05-28 | 주식회사 바스젠바이오 | 전립선암 발병의 위험도를 예측하기 위한 조성물 및 이를 이용한 방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| FI843529A0 (fi) | 1983-01-10 | 1984-09-10 | Gen Probe Inc | Foerfarande foer detektering, identifiering och kvantitering av organismer och virus. |
| US5288611A (en) | 1983-01-10 | 1994-02-22 | Gen-Probe Incorporated | Method for detecting, identifying, and quantitating organisms and viruses |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| DE69132531T2 (de) | 1990-12-06 | 2001-09-13 | Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) | Verbindungen und ihre Verwendung in einer binären Synthesestrategie |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| EP0655090B1 (en) | 1992-04-27 | 2000-12-27 | The Trustees Of Dartmouth College | Detection of gene sequences in biological fluids |
| WO1999032644A2 (en) * | 1997-12-22 | 1999-07-01 | Genset | Prostate cancer gene |
-
2006
- 2006-05-18 BR BRPI0610794-0A patent/BRPI0610794A2/pt not_active IP Right Cessation
- 2006-05-18 JP JP2008511868A patent/JP5227167B2/ja not_active Expired - Fee Related
- 2006-05-18 EP EP06728429A patent/EP1888772A1/en not_active Withdrawn
- 2006-05-18 US US11/920,590 patent/US20090317799A1/en not_active Abandoned
- 2006-05-18 WO PCT/IS2006/000012 patent/WO2006123369A1/en not_active Ceased
- 2006-05-18 CA CA002608567A patent/CA2608567A1/en not_active Abandoned
- 2006-05-18 AU AU2006248591A patent/AU2006248591B2/en not_active Ceased
- 2006-05-18 NZ NZ563913A patent/NZ563913A/en not_active IP Right Cessation
- 2006-05-18 MX MX2007014447A patent/MX2007014447A/es active IP Right Grant
-
2007
- 2007-11-18 IL IL187449A patent/IL187449A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008539782A (ja) | 2008-11-20 |
| JP5227167B2 (ja) | 2013-07-03 |
| CA2608567A1 (en) | 2006-11-23 |
| AU2006248591A1 (en) | 2006-11-23 |
| BRPI0610794A2 (pt) | 2010-11-09 |
| AU2006248591A9 (en) | 2006-11-23 |
| NZ563913A (en) | 2010-03-26 |
| AU2006248591B2 (en) | 2012-02-23 |
| IL187449A (en) | 2014-03-31 |
| AU2006248591A2 (en) | 2006-11-23 |
| WO2006123369A1 (en) | 2006-11-23 |
| WO2006123369A8 (en) | 2007-01-04 |
| EP1888772A1 (en) | 2008-02-20 |
| US20090317799A1 (en) | 2009-12-24 |
| IL187449A0 (en) | 2008-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009004522A (es) | Variantes de suceptibilidad a cancer en chr8q24.21. | |
| MX2009010439A (es) | Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. | |
| NZ591613A (en) | Polymorphic marker rs965513 for risk assessment of thyroid cancer | |
| IL202292A0 (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
| MY153198A (en) | Inhibitors of protein aggregation | |
| IN2012DN01403A (enExample) | ||
| ATE527385T1 (de) | Mit tumoren assoziierte genetische variationen | |
| IL197721A0 (en) | Compositions and methods for diagnosing and treating cancer | |
| PL2032166T3 (pl) | Kompozycje i sposoby diagnozowania i leczenia nowotworów | |
| PL3009148T3 (pl) | Kompozycje oraz sposoby leczenia i diagnozowania nowotworu | |
| WO2010004591A3 (en) | Genetic variants for breast cancer risk assessment | |
| EP2125887A4 (en) | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CANCER | |
| EP2156184A4 (en) | METHOD FOR DIAGNOSIS AND TREATMENT OF PROSTATE AND LUNG CANCER | |
| IL217120A0 (en) | Single nucleotide polymorphisms in brca1 and diagnostic methods of assessing cancer risk based on the same | |
| ATE449193T1 (de) | Verfahren zur bestimmung der kopienummer | |
| EP1961065A4 (en) | COMPOSITIONS AND METHOD FOR DIAGNOSIS AND TREATMENT OF CANCER | |
| WO2008088860A3 (en) | Polymorphisms in the egfr pathway as markers for cancer treatment | |
| EP2155249A4 (en) | COMPOSITIONS AND METHOD FOR DIAGNOSIS AND TREATMENT OF CANCER | |
| MX2010005057A (es) | Metodos y composiciones para uso de diagnostico en pacientes de cancer. | |
| MX2007014447A (es) | Variantes en cromosoma 8q24.21 que confieren riesgo de cancer. | |
| ZA200710910B (en) | Methods for the assessment of risk of developing lung cancer using analysis of genetic polymorphisms | |
| EP2164990A4 (en) | COMPOSITIONS, KITS AND METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CANCER | |
| MX2009004382A (es) | Variaciones geneticas asociadas con tumores. | |
| EP2099491A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER | |
| PT1611890E (pt) | Métodos para avaliação e tratamento do cancro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |